Summary NAV Details Dividend Detalis Investment Details Ratios Performance Portfolio Analysis In/Out Snapshot

Bajaj Finserv Healthcare Fund-Reg(G)

Summary Fund Name Bajaj Finserv Mutual Fund   Scheme Name Bajaj Finserv Healthcare Fund-Reg(G)   AMC Bajaj Finserv Asset Management Limited   Type Open ended scheme   Category Equity - Sectoral Fund - Pharma & Health Care   Launch Date 27-Dec-24   Fund Manager Nimesh Chandan , Sorbh Gupta , Siddharth Chaudhary   Face Value 10   Custodian Deutsche Bank A.G.   Net Assets (Rs. cr) 332.33   AMC Details Bajaj Finserv Asset Management Limited S. No. 208/1B, Lohagaon Viman Nagar Pune - 411014 Phone : 1800-309-3900 Fax : 020-67672550 service@bajajamc.com www.bajajamc.com Registrar & Transfer Agent Details KFin Technologies Limited Selenium Building, Tower-B, Plot No 31 & 32 Financial District,Nanakramguda, Serilingampally Hyderabad - 500 032 (040) 23312454 23320751 23320752 (040) 23311968 customercare@karvy.com https://mfs.kfintech.com/ NAV Details NAV Date 11-Jul-25 Max Entry Load % 0.00 NAV [Rs] 9.74 Max Exit Load % 0.00 Buy/Resale Price [Rs] 9.74 52 Week High[Rs] 10.13 (02-Jan-25) Sell/Repurchase Price [Rs] 9.74 52 Week Low[Rs] 8.52 (28-Feb-25) NAV Graph Raw Type Adj Type 1 Month   3 Months   6 Months   1 Year       3 Years     5 Years   SinceInception Dividend Details No Data Found Investment Details Objective The objective of the Scheme is to generate long term capital appreciation by predominantly investing in equity and equity related securities of pharma, healthcare and allied companies. Min. Investment (Rs.) 500 Increm.Investment (Rs.) 100 Investment Pattern Type Minimum % Maximum % Equity and Equity Related Securities of pharma, healthcare and allied companies 80 100 Debt and Money Market Instruments and Units of MF schemes 0 20 Equities and Equity related securities of other than pharma, healthcare and allied companies 0 20 Units issued by REITs and InvITs 0 10 SIP Details SIP MIN Investments(Rs.) 1000 SIP Incremental Investments(Rs.) 1 SIP Frequency   Daily No.of Investments Cheques Ratios Statistical Ratios Standard Deviation [%] 18.3637 Semi Standard Deviation [%] 0.4915 Beta [%] 0.6767 Sharpe Ratio [%] -0.1707 R-Square [%] 0.6265 Expense Ratio [%] 2.3700 AVG Ratio [%] 0.0409 Other Ratios Jenson Ratio [%] -0.0480 Treynor Ratio [%] -0.0463 Turnover Ratio [%] 0.0000 FAMA Ratio [%] -0.0494 SORTINO Ratio [%] 0.0498 What is Standard Deviation? Standard Deviation is the measure of the deviation in the returns of the portfolio. In Simple Words it tells us how much the return on the fund is deviating from the expected normal return. What is Jenson's Alpha? It measures whether the Scheme is generating excess returns over the normal returns.For example, if there are two mutual funds that both have a 12% return, a rational investor will want the fund that is less risky.If the value is positive, then the portfolio is earning excess returns. In other words, a positive value for Jensen's alpha means a fund manager has 'beat the market' w with his or her stock picking skills. The Higher the value the better the performance. Portfolio Analysis Allocations As on 30-Jun-2025 Fund Size : 332.33 (Cr.) Bar Chart 3D Bar Chart Pie Chart 3D Pie Chart Pyramid Chart 3D Pyramid Chart Market cap-wise Allocation Style Average Mkt Cap (Rs Cr) 79395.26 Market Capitalization % of Portfolio Large 95.39 Mid 2.08 Small NA Note: Large-Cap = 5000 Crs. and above, Mid-Cap = 2000 Crs. to 5000 Crs. and Small-Cap = less than 2000 Crs. Portfolio Concentration   % Net Assets Top 3 Sectors NA +  -  Top 5 Holdings 31.76 Divi's Lab 8.67 Sun Pharma Inds. 7.55 Cipla 6.08 Apollo Hospital Ent. 5.96 Glenmark Pharma 3.51 +  -  Top 10 Holdings 48.48 Divi's Lab 8.67 Sun Pharma Inds. 7.55 Cipla 6.08 Apollo Hospital Ent. 5.96 Glenmark Pharma 3.51 Biocon 3.51 Dr. Reddy's Lab 3.49 Piramal Pharma 3.34 Emcure Pharma 3.19 Abbott India 3.19 Holding Details Company Name % Hold   Divi's Laboratories Ltd. 8.67   Sun Pharmaceutical Industries Ltd. 7.55   Cipla Ltd. 6.08   Apollo Hospitals Enterprise Ltd. 5.96   Glenmark Pharmaceuticals Ltd. 3.51   Biocon Ltd. 3.51   Dr. Reddy's Laboratories Ltd. 3.49   Piramal Pharma Ltd. 3.34   Emcure Pharmaceuticals Ltd. 3.19   Abbott India Ltd. 3.19     Indicates an increase or decrease or no change in holding since last portfolio  Indicates a new holding since last portfolio. Detailed Portfolio Sector Allocation * (as % of equity portfolio) Sector Allocation   Reported Sectors Our Sectors   Chart Type :  Bar Chart 3D Bar Chart Pie Chart 3D Pie Chart *Pertains to the equity investments only. Performance 1 Week   [%] 1 Month   [%] 3 Months   [%] 6 Months   [%] 1 Year   [%] 3 Years   [%] 5 Years   [%] Since INC   [%] Scheme Return -0.29 0.90 9.18 -0.85 NA NA NA -2.58 Category Avg -0.86 1.20 9.49 0.24 13.82 24.51 21.80 16.83 Category Best -2.03 -3.55 3.11 -0.76 5.06 3.20 11.20 19.46 Category Worst -5.00 -7.10 -3.30 -6.89 -3.39 -6.39 5.83 -4.00 SENSEX -1.12 -0.02 9.77 6.62 3.26 14.89 17.65   NIFTY NA 0.03 10.17 7.33 3.43 15.75 18.49   *Equity - Returns upto 1 year are absolute and over 1 year are CAGR. *Debt - Returns upto 1 year are annualised and over 1 year are CAGR. What's In / What's Out What's in as on What's out as on Company Name Mkt Value Holdings (Rs.Cr) % Company Name Mkt Value Holdings (Rs.Cr) % Orchid Pharma Ltd. 4.441742 1.3836